From the tokenization of real-world assets to funding research on anti-aging therapeutics, Coinbase co-founder and CEO Brian Armstrong is focused on solving meta-problems for the benefit of society. Brian joins Elad Gil this episode to discuss the intersections of artificial intelligence, crypto rails, and biotechnology. He details Coinbase’s vision for agentic finance, as well as how Coinbase is becoming the ‘Everything Exchange’, which includes tokenized real-world stocks, stablecoin payment adoption, and prediction markets. Brian also introduces his new venture, New Limit, a company founded to tackle longevity through epigenetic reprogramming, and outlines initial therapeutic programs and the roadmap toward clinical trials.

Sign up for new podcasts every week. Email feedback to show@no-priors.com